Pharmacology, Toxicology and Pharmaceutical Science
Kynurenine
100%
Nerve Degeneration
100%
Hepatic Encephalopathy
100%
Liver Cirrhosis
40%
Tryptophan
26%
3 Hydroxykynurenine
20%
Quinolinic Acid
20%
Kynurenic Acid
20%
Picolinic Acid
13%
Liver Disease
6%
Nervous System Inflammation
6%
Blood-Brain Barrier
6%
Neuroprotective Agent
6%
Cytokine
6%
Neurotoxin
6%
High Performance Liquid Chromatography
6%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
6%
Indoleamine 2,3 Dioxygenase
6%
Disease Course
6%
Tryptophan 2,3 Dioxygenase
6%
Prospective Cohort Study
6%
Anthranilic Acid
6%
3 Hydroxyanthranilic Acid
6%
Ultra High Performance Liquid Chromatography
6%
Neuroscience
Neurodegeneration
100%
Kynurenine
100%
Hepatic Encephalopathy
100%
Tryptophan
26%
Quinolinic Acid
20%
Kynurenic Acid
20%
3-Hydroxykynurenine
20%
Astrocyte
6%
Neuroprotective Agent
6%
Blood Brain Barrier
6%
Blood Plasma
6%
Gas Chromatography
6%
NMDA Receptor Antagonist
6%
Neuronal Cell Death
6%
Indoleamine 2,3 Dioxygenase
6%
Mass Spectrometry
6%
Proinflammatory Cytokine
6%
Neurotoxin
6%
Tryptophan 2,3 Dioxygenase
6%
Anthranilic Acid
6%
3 Hydroxyanthranilic Acid
6%
Biochemistry, Genetics and Molecular Biology
Kynurenine Pathway
100%
Metabolite
54%
Tryptophan
36%
Kynurenine
36%
Enzyme
27%
Quinolinic Acid
27%
Kynurenic Acid
27%
High-Performance Liquid Chromatography
18%
Picolinic Acid
18%
Blood Brain Barrier
9%
Neuroinflammation
9%
Blood Plasma
9%
Astrocyte
9%
Neurotoxin
9%
Gas Chromatography-Mass Spectrometry
9%
Receptor Antagonist
9%
Indoleamine 2,3-dioxygenase
9%
Proinflammatory Cytokine
9%
NMDA Receptor
9%
Tryptophan 2,3-dioxygenase
9%
Prospective Cohort Study
9%
Anthranilic Acid
9%